A system for the measurement of gene targeting efficiency in human cell lines using an antibiotic resistance-GFP fusion gene

BioTechniques

Volumn 53, Issue 3, 2012, Pages 141-152

  Konishi, Yuko ^a   Karnan, Sivasundaram ^a   Takahashi, Miyuki ^a   Ota, Akinobu ^a   Damdindorj, Lkhagvasuren ^a   Hosokawa, Yoshitaka ^a   Konishi, Hiroyuki ^a  

^a AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Adeno associated virus; Gene editing; Genome modification; Homologous recombination

Indexed keywords

ADENOVIRUS VECTOR;

ARTICLE; CELL CLONE; CELL LINE; DNA SEQUENCE; FUSION GENE; GENE CONSTRUCT; GENE SILENCING; GENE TARGETING; HOMOLOGOUS RECOMBINATION; HUMAN; HUMAN CELL; HYGR 5' EGFP GENE; NUCLEOTIDE SEQUENCE; REPORTER GENE; SOMATIC CELL; START CODON;

ANTI-BACTERIAL AGENTS; CELL LINE; CINNAMATES; CLONING, MOLECULAR; DEPENDOVIRUS; DRUG RESISTANCE; FLOW CYTOMETRY; GENE TARGETING; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; HCT116 CELLS; HUMANS; HYGROMYCIN B; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); RECOMBINANT FUSION PROTEINS; TRANSFECTION;

ADENO-ASSOCIATED VIRUS;

EID: 84866354983     PISSN: 07366205     EISSN: 19409818     Source Type: Journal    
DOI: 10.2144/0000113911     Document Type: Article

References (38)

1. Shirasawa, S., M. Furuse, N. Yokoyama, and T. Sasazuki. 1993. Altered growth of human colon cancer cell lines disrupted at activated Ki-ras. Science 260:85-88.
2. Sedivy, J.M., B. Vogelstein, H.L. Liber, E.A. Hendrickson, and A. Rosmarin. 1999. Gene targeting in human cells without isogenic DNA. Science 283:9a.
3. Di Nicolantonio, F., S. Arena, M. Gallicchio, D. Zecchin, M. Martini, S.E. Flonta, G.M. Stella, S. Lamba, et al. 2008. Replacement of normal with mutant alleles in the genome of normal human cells unveils mutation-specific drug responses. Proc. Natl. Acad. Sci. USA 105:20864-20869.
4. Di Nicolantonio, F., S. Arena, J. Tabernero, S. Grosso, F. Molinari, T. Macarulla, M. Russo, C. Cancelliere, et al. 2010. Deregulation of the PI3K and KRAS signaling pathways in human cancer cells determines their response to everolimus. J. Clin. Invest. 120:2858-2866.
5. Russell, D.W. and R.K. Hirata. 1998. Human gene targeting by viral vectors. Nat. Genet. 18:325-330.
6. Hirata, R., J. Chamberlain, R. Dong, and D.W. Russell. 2002. Targeted transgene insertion into human chromosomes by adeno-associated virus vectors. Nat. Biotechnol. 20:735-738.
7. Rago, C., B. Vogelstein, and F. Bunz. 2007. Genetic knockouts and knockins in human somatic cells. Nat. Protocols 2:2734-2746.
8. Konishi, H., J. Lauring, J.P. Garay, B. Karakas, A.M. Abukhdeir, J.P. Gustin, Y. Konishi, and B.H. Park. 2007. A PCR-based high-throughput screen with multiround sample pooling: application to somatic cell gene targeting. Nat. Protocols 2:2865-2874.
9. Khan, I.F., R.K. Hirata, and D.W. Russell. 2011. AAV-mediated gene targeting methods for human cells. Nat. Protocols 6:482-501.
10. Arbones, M.L., H.A. Austin, D.J. Capon, and G. Greenburg. 1994. Gene targeting in normal somatic cells: inactivation of the interferon-gamma receptor in myoblasts. Nat. Genet. 6:90-97.
11. Hirata, R.K. and D.W. Russell. 2000. Design and packaging of adeno-associated virus gene targeting vectors. J. Virol. 74:4612-4620.
12. Porteus, M.H. and D. Baltimore. 2003. Chimeric nucleases stimulate gene targeting in human cells. Science 300:763.
13. Teschendorf, C., K.H. Warrington, Jr., D.W. Siemann, and N. Muzyczka. 2002. Comparison of the EF-1 alpha and the CMV promoter for engineering stable tumor cell lines using recombinant adeno-associated virus. Anticancer Res. 22:3325-3330.
14. Gopalkrishnan, R.V., K.A. Christiansen, N.I. Goldstein, R.A. DePinho, and P.B. Fisher. 1999. Use of the human EF-1alpha promoter for expression can significantly increase success in establishing stable cell lines with consistent expression: a study using the tetracycline-inducible system in human cancer cells. Nucleic Acids Res. 27:4775-4782.
15. Najjar, S.M. and R.E. Lewis. 1999. Persistent expression of foreign genes in cultured hepatocytes: expression vectors. Gene 230:41-45.
16. Topaloglu, O., P.J. Hurley, O. Yildirim, C.I. Civin, and F. Bunz. 2005. Improved methods for the generation of human gene knockout and knockin cell lines. Nucleic Acids Res. 33:e158.
17. Konishi, H., B. Karakas, A.M. Abukhdeir, J. Lauring, J.P. Gustin, J.P. Garay, Y. Konishi, E. Gallmeier, et al. 2007. Knock-in of mutant K-ras in nontumorigenic human epithelial cells as a new model for studying K-ras mediated transformation. Cancer Res. 67:8460-8467.
18. Jasin, M. and P. Berg. 1988. Homologous integration in mammalian cells without target gene selection. Genes Dev. 2:1353-1363.
19. Sedivy, J.M. and P.A. Sharp. 1989. Positive genetic selection for gene disruption in mammalian cells by homologous recombination. Proc. Natl. Acad. Sci. USA 86:227-231.
20. Hennecke, M., M. Kwissa, K. Metzger, A. Oumard, A. Kroger, R. Schirmbeck, J. Reimann, and H. Hauser. 2001. Composition and arrangement of genes define the strength of IRES-driven translation in bicistronic mRNAs. Nucleic Acids Res. 29:3327-3334.
21. Borman, A.M., P. Le Mercier, M. Girard, and K.M. Kean. 1997. Comparison of picornaviral IRES-driven internal initiation of translation in cultured cells of different origins. Nucleic Acids Res. 25:925-932.
22. Roberts, L.O., R.A. Seamons, and G.J. Belsham. 1998. Recognition of picornavirus internal ribosome entry sites within cells; influence of cellular and viral proteins. RNA 4:520-529.
23. Filbin, M.E. and J.S. Kieft. 2009. Toward a structural understanding of IRES RNA function. Curr. Opin. Struct. Biol. 19:267-276.
24. Komar, A.A. and M. Hatzoglou. 2011. Cellular IRES-mediated translation: the war of ITAFs in pathophysiological states. Cell Cycle 10:229-240.
25. So, S., Y. Nomura, N. Adachi, Y. Kobayashi, T. Hori, Y. Kurihara, and H. Koyama. 2006. Enhanced gene targeting efficiency by siRNA that silences the expression of the Bloom syndrome gene in human cells. Genes Cells 11:363-371.
26. Ohbayashi, F., M.A. Balamotis, A. Kishimoto, E. Aizawa, A. Diaz, P. Hasty, F.L. Graham, C.T. Caskey, and K. Mitani. 2005. Correction of chromosomal mutation and random integration in embryonic stem cells with helper-dependent adenoviral vectors. Proc. Natl. Acad. Sci. USA 102:13628-13633.
27. Swann, P.F., T.R. Waters, D.C. Moulton, Y.Z. Xu, Q. Zheng, M. Edwards, and R. Mace. 1996. Role of postreplicative DNA mismatch repair in the cytotoxic action of thioguanine. Science 273:1109-1111.
28. Carroll, D. 2011. Zinc-finger nucleases: a panoramic view. Curr. Gene Ther. 11:2-10.
29. Miller, J.C., S. Tan, G. Qiao, K.A. Barlow, J. Wang, D.F. Xia, X. Meng, D.E. Paschon, et al. 2011. A TALE nuclease architecture for efficient genome editing. Nat. Biotechnol. 29:143-148.
30. Mussolino, C. and T. Cathomen. 2012. TALE nucleases: tailored genome engineering made easy. Curr. Opin. Biotechnol. Feb 17. [Epub ahead of print]
31. Hucl, T., C. Rago, E. Gallmeier, J.R. Brody, M. Gorospe, and S.E. Kern. 2008. A syngeneic variance library for functional annotation of human variation: application to BRCA2. Cancer Res. 68:5023-5030.
32. Gustin, J.P., B. Karakas, M.B. Weiss, A.M. Abukhdeir, J. Lauring, J.P. Garay, D. Cosgrove, A. Tamaki, et al. 2009. Knockin of mutant PIK3CA activates multiple oncogenic pathways. Proc. Natl. Acad. Sci. USA 106:2835-2840.
33. Yun, J., C. Rago, I. Cheong, R. Pagliarini, P. Angenendt, H. Rajagopalan, K. Schmidt, J.K. Willson, et al. 2009. Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells. Science 325:1555-1559.
34. Vitolo, M.I., M.B. Weiss, M. Szmacinski, K. Tahir, T. Waldman, B.H. Park, S.S. Martin, D.J. Weber, and K.E. Bachman. 2009. Deletion of PTEN promotes tumorigenic signaling, resistance to anoikis, and altered response to chemotherapeutic agents in human mammary epithelial cells. Cancer Res. 69:8275-8283.
35. Chung, J.H. and F. Bunz. 2010. Cdk2 is required for p53-independent G2/M checkpoint control. PLoS Genet. 6:e1000863.
36. Fattah, F., E.H. Lee, N. Weisensel, Y. Wang, N. Lichter, and E.A. Hendrickson. 2010. Ku regulates the non-homologous end joining pathway choice of DNA double-strand break repair in human somatic cells. PLoS Genet. 6:e1000855.
37. Solomon, D.A., T. Kim, L.A. Diaz-Martinez, J. Fair, A.G. Elkahloun, B.T. Harris, J.A. Toretsky, S.A. Rosenberg, et al. 2011. Mutational inactivation of STAG2 causes aneuploidy in human cancer. Science 333:1039-1043.
38. Konishi, H., M. Mohseni, A. Tamaki, J.P. Garay, S. Croessmann, S. Karnan, A. Ota, H.Y. Wong, et al. 2011. Mutation of a single allele of the cancer susceptibility gene BRCA1 leads to genomic instability in human breast epithelial cells. Proc. Natl. Acad. Sci. USA 108:17773-17778.